28.01.2024, 1446 Zeichen
Semperit: The Semperit Group is celebrating its 200^th anniversary in 2024. Founded in 1824, the company is taking this anniversary as an opportunity to highlight its centuries-long tradition but also its path to a successful future in a variety of ways under the motto “200 Years of Semperit – Experience for Tomorrow”. On the 200-year website www.200.semperitgroup.com launched today, Semperit looks back on the company’s history, which is a story of outstanding personalities and innovative ideas, of resounding successes as well as overcoming crises that jeopardized the company’s existence. At the same time, solutions and people are presented who are already working on Semperit’s future successes today.
Semperit: weekly performance:
UBM: The ground-breaking ceremony for the exclusive HAVN residential and office building developed by UBM Development marks another prominent addition to the Zollhafen Mainz. Located directly on the waterfront promenade of the Nordmole, the project comprises 44 condominiums and 5 office units with a total of around 6,700 square meters of gross floor area above ground. The underground car park has a total of 26 parking spaces, which are pre-equipped for the connection of wall boxes, as well as a bright and spacious bicycle garage. HAVN is scheduled for completion in Q1/2026.
UBM: weekly performance:
(From the 21st Austria weekly https://www.boerse-social.com/21staustria (25/01/2024)
Zertifikat des Tages: Erste Group Immo-Zertifikat NTR als 2. Kauf ins Real Money Depot bei dad.at und die Begründung
Aktien auf dem Radar:RHI Magnesita, Rosenbauer, EuroTeleSites AG, Amag, Lenzing, Semperit, OMV, Österreichische Post, ATX, ATX Prime, ATX TR, Andritz, Erste Group, Uniqa, Porr, DO&CO, VIG, Rosgix, Bawag, Addiko Bank, AT&S, Kapsch TrafficCom, Josef Manner & Comp. AG, Marinomed Biotech, Pierer Mobility, Wienerberger, Warimpex, Palfinger, UBM, Frequentis, Flughafen Wien.
Valneva
Valneva ist ein Impfstoffunternehmen, das sich auf die Entwicklung und Vermarktung von prophylaktischen Impfstoffen gegen Infektionskrankheiten mit hohem ungedeckten medizinischen Bedarf spezialisiert hat.
>> Besuchen Sie 68 weitere Partner auf boerse-social.com/partner
Die Useletter "Morning Xpresso" und "Evening Xtrakt" heben sich deutlich von den gängigen Newslettern ab.
Beispiele ansehen bzw. kostenfrei anmelden. Wichtige Börse-Infos garantiert.
Newsletter abonnieren
Infos über neue Financial Literacy Audio Files für die Runplugged App
(kostenfrei downloaden über http://runplugged.com/spreadit)
per Newsletter erhalten